Ingevity Corp

For the period ended Dec 31, 2024. Filed Feb 19, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 19, 2025

NGVT$60.78-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Earnings (Loss) per Share

Index

Note 20: Earnings (Loss) per Share

	Years Ended December 31,
In millions (except share (in thousands) and per share data)	2024	2023	2022
Net income (loss)	$(430.3)	$(5.4)	$211.6
Basic and Diluted earnings (loss) per share (1)
Basic earnings (loss) per share	$(11.85)	$(0.15)	$5.54
Diluted earnings (loss) per share	$(11.85)	$(0.15)	$5.50
Shares
Weighted average number of shares of common stock outstanding - Basic	36,323	36,496	38,179
Weighted average additional shares assuming conversion of potential common shares (2)	—	—	292
Shares - diluted basis	36,323	36,496	38,471

(1) Diluted earnings (loss) per share is calculated using net income (loss) available to common stockholders divided by diluted weighted average shares of common shares outstanding during each period, which includes the dilutive effect of outstanding equity awards.

(2) For the years ended December 31, 2024 and 2023, all potentially dilutive common shares were excluded from the calculation of diluted earnings (loss) per share as we had a net loss for the period.

The following average number of potential common shares were antidilutive and, therefore, were not included in the diluted earnings per share calculation:

	Years Ended December 31,
In thousands	2024	2023	2022
Average number of potential common shares - antidilutive	444	571	204

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.